
Andrzej Rostek
- Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said on Wednesday that the European Commission has approved a new tablet form of Evrysdi for those affected by spinal muscular atrophy.
- The Evrysdi 5 mg tablet is designed to be taken with or without food and